These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7371709)

  • 21. A pharmacokinetic and pharmacodynamic assessment of a combined slow-release metoprolol-chlorthalidone preparation.
    Kendall MJ; Lambert L; Quarterman CP; John VA
    J Clin Hosp Pharm; 1981 Dec; 6(4):259-65. PubMed ID: 7338557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pharmacokinetic and pharmacodynamic comparison of immediate-release metoprolol and extended-release metoprolol CR/XL in patients with suspected acute myocardial infarction: a randomized, open-label study.
    Karlson BW; Dellborg M; Gullestad L; Aberg J; Sugg J; Herlitz J
    Cardiology; 2014; 127(2):73-82. PubMed ID: 24247812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Slow-release metoprolol in angina pectoris. A comparative study of a cardioselective beta-blocking drug, metoprolol, in ordinary and slow-release tablets (Durules) in the treatment of angina pectoris.
    Uusitalo AJ; Keyriläinen O
    Ann Clin Res; 1979 Oct; 11(5):199-204. PubMed ID: 44671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
    Floras JS; Jones JV; Hassan MO; Sleight P
    Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CNS-related performance and haemodynamics of metoprolol-Oros and propranolol after single and 3 days dosing in healthy volunteers.
    van Steveninck AL; Pieters MS; Schoemaker HC; Breimer DD; Cohen AF
    Br J Clin Pharmacol; 1993 Feb; 35(2):114-20. PubMed ID: 8443028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relative activities of atenolol and metoprolol on the cardiovascular system of man.
    Harry JD; Cruickshank JM; Young J; Barker N
    Eur J Clin Pharmacol; 1981; 20(1):9-15. PubMed ID: 7308277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sustained release metoprolol: a comparison with conventional formulation in the treatment of hypertension.
    Logan RL; Goldstraw PW; Kiddle GB; Flacks LM; Watt M
    N Z Med J; 1981 Jul; 93(687):1-2. PubMed ID: 7022275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic and pharmacodynamic properties of metoprolol in patients with impaired renal function.
    Jordö L; Attman PO; Aurell M; Johansson L; Johnsson G; Regårdh CG
    Clin Pharmacokinet; 1980; 5(2):169-80. PubMed ID: 6102500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic and pharmacodynamic comparison of conventional and controlled release formulations of metoprolol [correction of motoprolol] in healthy Chinese subjects.
    Lee YT; Liau CS; Wong EC; Chen WJ; Chen MF; Chen CC
    Cardiovasc Drugs Ther; 1989 Aug; 3(4):529-33. PubMed ID: 2488104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative pharmacokinetic profiles of metoprolol and chlorthalidone administered alone or in combination to healthy volunteers.
    Godbillon J; Gerardin A; John VA; Theobald W
    Eur J Clin Pharmacol; 1983; 24(5):655-60. PubMed ID: 6873146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease.
    Plosker GL; Clissold SP
    Drugs; 1992 Mar; 43(3):382-414. PubMed ID: 1374320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative bioavailability and effect studies on metoprolol administered as ordinary and slow-release tablets in single and multiple doses.
    Regårdh CG; Johnsson G; Jordö L; Sölvell L
    Acta Pharmacol Toxicol (Copenh); 1975; 36(Suppl 5):45-58. PubMed ID: 1079687
    [No Abstract]   [Full Text] [Related]  

  • 33. Beta-blockers: once or three times a day?
    Reybrouck T; Amery A; Fagard R; Jousten P; Lijnen P; Meulepas E
    Br Med J; 1978 May; 1(6124):1386-8. PubMed ID: 348260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the duration of effect of metoprolol and a sustained release formulation of metoprolol (betaloc-SA).
    Harron DW; Shanks RG
    Br J Clin Pharmacol; 1981 May; 11(5):518-20. PubMed ID: 7272165
    [No Abstract]   [Full Text] [Related]  

  • 35. Bioequivalence, pharmacokinetic and pharmacodynamic response to combined extended release formulations of felodipine and metoprolol in healthy volunteers.
    Aberg J; Abrahamsson B; Grind M; Nyberg G; Olofsson B
    Eur J Clin Pharmacol; 1997; 52(6):471-7. PubMed ID: 9342583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma concentrations and beta-blocking effects in normal volunteers after intravenous doses of metoprolol and propranolol.
    Regårdh CG; Johnsson G; Jordö L; Lungborg P; Persson BA; Rönn O
    J Cardiovasc Pharmacol; 1980; 2(6):715-23. PubMed ID: 6160322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic and pharmacodynamic properties of controlled release (CR/ZOK) metoprolol in healthy Oriental subjects: a comparison with conventional formulations of metoprolol and atenolol.
    Darmansjah I; Wong E; Setiawati A; Moeloek D; Irawati D; Siagian M; Muchtar A
    J Clin Pharmacol; 1990 Feb; 30(S2):S39-45. PubMed ID: 2312778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic and pharmacodynamic comparison of controlled-release carvedilol and immediate-release carvedilol at steady state in patients with hypertension.
    Henderson LS; Tenero DM; Baidoo CA; Campanile AM; Harter AH; Boyle D; Danoff TM
    Am J Cardiol; 2006 Oct; 98(7A):17L-26L. PubMed ID: 17023228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ["Slow-release" metoprolol in the therapy of hypertension: comparison with divided doses].
    Pirani R; Buzzetti G; Gruppillo P; Padovan G; Masoni C
    Clin Ter; 1981 Sep; 98(6):627-41. PubMed ID: 7026144
    [No Abstract]   [Full Text] [Related]  

  • 40. Duration of beta-blockade with metoprolol and atenolol: influence of drug oxidation.
    Freestone S; Lennard MS; Silas JH; Ramsay LE
    Postgrad Med J; 1983; 59 Suppl 3():36-7. PubMed ID: 6647208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.